Insecticides (India) Limited AI Stock Analysis
Want to see IN:INSECTICID full AI Analyst Report?
Insecticides (India) Limited (INSECTICID) AI Stock Analysis
Insecticides (India) Limited
(NSE:INSECTICID)
The overall score of 62 reflects a balance between a highly conservative balance sheet and an attractive valuation, which are significantly offset by poor cash flow generation and a persistent bearish technical downtrend.
Insecticides (India) Limited (INSECTICID) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 16.67B
- Dividend Yield
- 0.91%
- Average Volume (3M)
- 975
- Price to Earnings (P/E)
- 12.7
- Beta (1Y)
- 1.01
- Revenue Growth
- 1.26%
- EPS Growth
- -16.43%
- Country
- India
- Employees
- 1,615
- Sector
- General
- Sector Strength
- 55
- Industry
- Agricultural Inputs
Insecticides (India) Limited Business Overview & Revenue Model
Company Description
Insecticides (India) Limited operates as a prominent entity within the agrochemical industry, engaging in the manufacture and global sale of a diverse array of agricultural products, primarily for crop protection and enhancement. The company's extens...
How the Company Makes Money
Insecticides (India) Limited primarily makes money by selling branded and/or formulated crop protection products to the agricultural market. Its revenue is mainly generated from (1) domestic sales of agrochemical formulations (such as insecticides, h...
Insecticides (India) Limited Financial Statement Overview
Summary
The financial profile is anchored by a highly stable balance sheet with minimal leverage (D/E 0.12x) and steady revenue growth, but is significantly weighed down by weak free cash flow conversion and marginally contracting net profit margins.
Income Statement
75PositiveBalance Sheet
88Very PositiveCash Flow
45Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.09B | 21.40B | 20.00B | 19.56B | 17.97B | 14.98B |
| Gross Profit | 5.74B | 4.76B | 3.98B | 2.82B | 3.99B | 3.79B |
| EBITDA | 2.14B | 2.39B | 2.29B | 1.72B | 1.21B | 1.73B |
| Net Income | 1.22B | 1.39B | 1.42B | 1.02B | 632.11M | 1.07B |
Balance Sheet | ||||||
| Total Assets | 22.29B | 19.85B | 18.98B | 17.13B | 16.96B | 13.96B |
| Cash, Cash Equivalents and Short-Term Investments | 372.23M | 917.91M | 666.26M | 613.50M | 196.42M | 360.96M |
| Total Debt | 2.48B | 1.57B | 1.05B | 873.09M | 1.63B | 539.50M |
| Total Liabilities | 9.09B | 7.71B | 8.14B | 7.00B | 7.78B | 5.27B |
| Stockholders Equity | 13.20B | 12.14B | 10.85B | 10.14B | 9.18B | 8.70B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 1.18M | 561.68M | 1.35B | -980.91M | 675.70M |
| Operating Cash Flow | 0 | 928.61M | 934.57M | 1.84B | -106.33M | 1.35B |
| Investing Cash Flow | 0 | -907.75M | -377.20M | -429.91M | -864.03M | 93.09M |
| Financing Cash Flow | 0 | 296.59M | -610.92M | -980.58M | 796.80M | -1.15B |
Insecticides (India) Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INSECTICID, the sentiment is Neutral. The current price of 544.75 is above the 20-day moving average (MA) of 533.37, below the 50-day MA of 566.77, and below the 200-day MA of 625.16, indicating a neutral trend. The MACD of -6.31 indicates Negative momentum. The RSI at 50.71 is Neutral, neither overbought nor oversold. The STOCH value of 31.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:INSECTICID.
Insecticides (India) Limited Peers Comparison
Overall Rating
IN:BHARATRAS73Outperform
IN:DHANUKA73Outperform
IN:RALLIS63Neutral
IN:INSECTICID62Neutral
IN:IPL60Neutral
IN:PIIND58Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 73Outperform | INR 16.04B | 7.03 | ― | 0.05% | -5.17% | 4.24% | |
| 73Outperform | INR 41.70B | 14.96 | ― | 0.21% | -0.06% | 0.75% | |
| 63Neutral | INR 36.78B | 18.73 | ― | 1.59% | 6.82% | 11.93% | |
| 62Neutral | INR 15.85B | 12.70 | ― | 0.91% | 1.26% | -16.43% | |
| 60Neutral | INR 13.45B | 14.02 | ― | 0.65% | 2.89% | -9.47% | |
| 58Neutral | INR 253.46B | 28.06 | ― | 0.61% | -14.95% | -41.96% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:INSECTICID | Insecticides (India) Limited | 544.75 | -145.99 | -21.13% | |
| IN:BHARATRAS | Bharat Rasayan Limited | 963.55 | -1615.11 | -62.63% | |
| IN:DHANUKA | Dhanuka Agritech Limited | 935.35 | -270.28 | -22.42% | |
| IN:IPL | India Pesticides Ltd. | 114.75 | -60.56 | -34.54% | |
| IN:PIIND | PI Industries Limited | 1623.00 | -1800.01 | -52.59% | |
| IN:RALLIS | Rallis India Limited | 189.15 | -57.79 | -23.40% |
Insecticides (India) Limited Corporate Events
Insecticides (India) to Meet Analysts at Arihant Capital Virtual Conference on Sept. 28
Insecticides (India) Limited has announced that its officials will participate in the Bharat Connect virtual conference hosted by Arihant Capital on 28 September 2026, where they will hold a group meeting with analysts and institutional investors at...
Insecticides (India) Limited Conducts 29th AGM via Video Conferencing
Insecticides (India) Limited held its 29th Annual General Meeting on August 12, 2026, conducted entirely via video conferencing in line with Ministry of Corporate Affairs and SEBI guidelines. The AGM was chaired by Hari Chand Aggarwal, with all key d...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 30, 2026
